W, B., HE, R., DV, W., F, P., H, Y., BD, R., . . . SA, A. (2026). CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-72685-1
Chicago Style (17th ed.) CitationW, Bourgeois, et al. "CRISPR Base Editor Screening Identifies Spectrum of MEN1 Mutations Impacting Menin Inhibitors in Clinical Trials." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-72685-1.
MLA (9th ed.) CitationW, Bourgeois, et al. "CRISPR Base Editor Screening Identifies Spectrum of MEN1 Mutations Impacting Menin Inhibitors in Clinical Trials." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-72685-1.